 Receptor Activator of Nuclear Factor-kappa B
"Receptor Activator of Nuclear Factor-kappa B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor necrosis factor receptor family member that is specific for RANK LIGAND and plays a role in bone homeostasis by regulating osteoclastogenesis. It is also expressed on DENDRITIC CELLS where it plays a role in regulating dendritic cell survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.
| Descriptor ID |
D053246
|
| MeSH Number(s) |
D12.776.543.750.705.852.760.345
|
| Concept/Terms |
Receptor Activator of Nuclear Factor-kappa B- Receptor Activator of Nuclear Factor-kappa B
- Receptor Activator of Nuclear Factor kappa B
- Receptor Activator of NF-kappa B
- Receptor Activator of NF kappa B
- TRANCE-R
- TRANCE R
- TRANCE Receptor
- RANK Protein
- Receptor Activator of NF-kappaB
- Receptor Activator of NF kappaB
- NF-KappaB Receptor Activator
- Activator, NF-KappaB Receptor
- NF KappaB Receptor Activator
- Receptor Activator, NF-KappaB
- Receptors, Tumor Necrosis Factor, Member 11a
- Receptor Activator of Nuclear Factor-kappaB
- Receptor Activator of Nuclear Factor kappaB
- Tumor Necrosis Factor Receptor Superfamily, Member 11a
- NF-Kappa B Receptor Activator
- NF Kappa B Receptor Activator
- CD265 Antigen
- Antigen, CD265
- TNFRSF11A Protein
|
Below are MeSH descriptors whose meaning is more general than "Receptor Activator of Nuclear Factor-kappa B".
Below are MeSH descriptors whose meaning is more specific than "Receptor Activator of Nuclear Factor-kappa B".
This graph shows the total number of publications written about "Receptor Activator of Nuclear Factor-kappa B" by people in this website by year, and whether "Receptor Activator of Nuclear Factor-kappa B" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2007 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptor Activator of Nuclear Factor-kappa B" by people in Profiles.
-
Szwarc MM, Hai L, Maurya VK, Rajapakshe K, Perera D, Ittmann MM, Mo Q, Lin Y, Bettini ML, Coarfa C, Lydon JP. Histopathologic and transcriptomic phenotypes of a conditional RANKL transgenic mouse thymus. Cytokine. 2022 12; 160:156022.
-
Iwamoto SJ, Rothman MS, Duan S, Baker JC, Mumm S, Whyte MP. Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK. Bone. 2020 04; 133:115224.
-
Yamagishi T, Kawashima H, Ogose A, Ariizumi T, Oike N, Sasaki T, Hatano H, Ohashi R, Umezu H, Ajioka Y, Endo N. Expression Profiling of Receptor-Activator of Nuclear Factor-Kappa B Ligand in Soft Tissue Tumors. Tohoku J Exp Med. 2019 06; 248(2):87-97.
-
Szwarc MM, Kommagani R, Jacob AP, Dougall WC, Ittmann MM, Lydon JP. Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors. PLoS One. 2015; 10(6):e0128467.
-
Menon P, Yin G, Smolock EM, Zuscik MJ, Yan C, Berk BC. GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass. J Cell Physiol. 2010 Nov; 225(3):777-85.
-
Dovio A, Allasino B, Palmas E, Ventura M, Pia A, Saba L, Aroasio E, Terzolo M, Angeli A. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile. J Clin Endocrinol Metab. 2007 May; 92(5):1803-8.
-
Wei X, Zhang X, Zuscik MJ, Drissi MH, Schwarz EM, O'Keefe RJ. Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. J Bone Miner Res. 2005 Jul; 20(7):1136-48.
-
Okamatsu Y, Kim D, Battaglino R, Sasaki H, Sp?te U, Stashenko P. MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival. J Immunol. 2004 Aug 01; 173(3):2084-90.
-
Battaglino R, Fu J, Sp?te U, Ersoy U, Joe M, Sedaghat L, Stashenko P. Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res. 2004 Sep; 19(9):1420-31.
-
Fan X, Roy E, Zhu L, Murphy TC, Ackert-Bicknell C, Hart CM, Rosen C, Nanes MS, Rubin J. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology. 2004 Feb; 145(2):751-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|